Shoulder Innovations, Inc. (NYSE: SI)

Shoulder Innovations is a commercial stage medical technology company dedicated to transforming shoulder surgical care. The company focuses exclusively on shoulder arthroplasty and provides an integrated ecosystem that includes advanced implant systems preoperative planning technology instrument sets specialist support and surgeon collaboration tools. This ecosystem addresses limitations of existing implants by improving fixation functionality longevity and procedural efficiency across hospital and outpatient settings. The implant portfolio features interchangeable anatomic and total shoulder systems that share a common surgical technique and a two tray instrument platform. By integrating planning implants and support Shoulder Innovations aims to deliver reproducible outcomes and reduce complexity for surgeons and healthcare facilities.

Revenue is generated primarily from the sale of its implant systems for anatomic and total shoulder arthroplasty procedures. The company also offers its FDA cleared Preoperative Planning software which creates patient specific three dimensional plans and provides related services such as training education and case support. In 2025 the company reported that approximately 250,000 shoulder arthroplasty procedures were performed in the United States representing a market opportunity of about $1.7 billion. Shoulder Innovations derives its revenue from product sales and service fees tied to the use of its technology in both inpatient and outpatient environments. Its customers include hospitals ambulatory surgery centers and outpatient facilities that perform shoulder replacement surgeries.

Shoulder Innovations holds a differentiated position in the orthopedic market by concentrating solely on shoulder care while larger competitors such as Stryker Zimmer Biomet Smith & Nephew and Arthrex offer broad joint portfolios. Its proprietary InSet glenoid technology reduces micromotion and aims to lower revision rates a claim supported by long term clinical data showing no loosening over nine years. The company’s two tray instrument system cuts operating room footprint and sterilization time compared with traditional six to nine tray setups giving it an advantage in ambulatory surgery centers. Strong clinical evidence including peer reviewed studies demonstrating improved ASES scores and durability reinforces its reputation as a leader in shoulder arthroplasty innovation. The firm also benefits from a specialized sales organization that focuses exclusively on shoulder surgeons enabling deeper relationships and tailored support than generalized orthopedic suppliers.

Shoulder Innovations serves hospitals ambulatory surgery centers and outpatient surgery centers that perform shoulder arthroplasty procedures. The company works directly with surgeons through a dedicated sales force a clinical education team and a network of independent distributors. It targets high volume surgeons who conduct the majority of shoulder replacement procedures in the United States. By providing specialized support training and collaborative forums Shoulder Innovations seeks to build long term loyalty among its surgeon customers.